RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease

Ms Zehra Arkir, consultant clinical scientist, Viapath, St Thomas' Hospital. Ms Arkir was a stakeholder on the analytical evaluation of similar assays evaluated in NICE diagnostics guidance on therapeutic monitoring of TNF-alpha inhibitors in Crohn's disease. She has conducted analytical evaluations of the RIDASCREEN tests which were provided free of charge by R-Biopharm.

Ms Mandy Robinson, advanced nurse practitioner/inflammatory bowel disease nurse, Newcastle-upon-Tyne Hospitals NHS Trust (no conflicts of interest declared).

Dr Ally Speight, consultant gastroenterologist, Newcastle-upon-Tyne Hospitals NHS Trust (no conflicts of interest declared).

Mr Nick Unsworth, senior clinical scientist, Imperial College Healthcare NHS Trust. Mr Unsworth has previously done analytical evaluations of the RIDASCREEN tests, which were provided free of charge by R-Biopharm.